Tweet
Prívate Investors or Funders
We are seeking investor partnerships to capitalize the acquisition of $70-80 million in lien-secured medical AR assets.
Our recoveries for these Assets are backed by numerous layers of securities, including lien privileges as well as statutory, contractual, and regulatory protections. We currently project that we will collect 65-70% of the book value of assets throughout the course of this investment.
We will be forming an independent entity to acquire and maintain all of the rights, title, and interest in these assets on behalf of the participating Members. In order to capitalize the acquisition, we are seeking to raise up to $20,000,000.00 by issuing 100 shares of Class A Membership interests to capital investors. The shares will be valued at $200,000.00 per unit, and will be sold on a first-come, first-serve basis to qualified investors.
The Offering will be memorialized under a Private Placement Memorandum.
As we collect the proceeds of the AR, Class A Members (Investors) will receive all distributions until such time that their investment is paid back in full, in addition to a 40% ROI. In total, the investors would receive the first $28,000,000.00 in distributions from the proceeds of the AR assets.
The remaining proceeds will be paid to the company’s equity shareholders.
Our current goal is to sell at least 10% of the available shares by June 30, 2020, with the remaining shares to be sold before the close date of this offering on July 31, 2020.
Our recoveries for these Assets are backed by numerous layers of securities, including lien privileges as well as statutory, contractual, and regulatory protections. We currently project that we will collect 65-70% of the book value of assets throughout the course of this investment.
We will be forming an independent entity to acquire and maintain all of the rights, title, and interest in these assets on behalf of the participating Members. In order to capitalize the acquisition, we are seeking to raise up to $20,000,000.00 by issuing 100 shares of Class A Membership interests to capital investors. The shares will be valued at $200,000.00 per unit, and will be sold on a first-come, first-serve basis to qualified investors.
The Offering will be memorialized under a Private Placement Memorandum.
As we collect the proceeds of the AR, Class A Members (Investors) will receive all distributions until such time that their investment is paid back in full, in addition to a 40% ROI. In total, the investors would receive the first $28,000,000.00 in distributions from the proceeds of the AR assets.
The remaining proceeds will be paid to the company’s equity shareholders.
Our current goal is to sell at least 10% of the available shares by June 30, 2020, with the remaining shares to be sold before the close date of this offering on July 31, 2020.
